Viatris gained China approval for the commercialization of Yupelri.

1 report, 0 independent Updated Jun 27

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

mainland China Mylan

Keep exploring

Part of

Viatris is managing ongoing dialogues with the FDA, addressing investor queries regarding share repurchases, and reporting on operational growth in Europe and China. All 1 developments

The entities involved

mainland China
geopolitical area under the jurisdiction of the People's Republic of China, excluding Special Administrative Regions
- HKEX reinforces Hong Kong's role connecting Mainland China. HKEX and Bursa Malaysia collaborate on co-branded benchmarks.Mon 06:23
- The company sold the Mainland China operations of Pizza Hut in a separate transaction for an aggregate of $2.7 billion. Chris Turner was appointed CEO of Yum! Brands.Mon 04:17
Mylan
former pharmaceutical company
- Mylan and Zymeworks are involved in a deal aimed at bolstering Zymeworks’ commercial portfolio, related to COPD therapy.Mon 11:01
- Zymeworks is leveraging Irish tax attributes as part of its deal with Mylan.Mon 11:01

Coverage

Newest first; wire copies grouped

Jun 27Unknown outlet